台灣臨床試驗主持人資料庫|TPIDB

2017-11-30 - 2019-12-30

Phase II

An Adaptive Seamless Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Investigate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Condition/Disease

Primary IgA Nephropathy
Test Drug

LNP023

Participate Sites
4Sites

Terminated4Sites

吳麥斯

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

2018-03-08 - 2021-07-04

Phase III

A PHASE 3 MULTI-CENTER, LONG-TERM EXTENSION STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ABROCITINIB, WITH OR WITHOUT TOPICAL MEDICATIONS, ADMINISTERED TO SUBJECTS AGED 12 YEARS AND OLDER WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Condition/Disease

Atopic dermatitis (AD)
Test Drug

PF-04965842

Participate Sites
9Sites

Recruiting9Sites

李婉若

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Dermatology

2016-08-08 - 2017-10-31

Phase III

BI 655066/ABBV-066 (Risankizumab) Versus Adalimumab in a Randomized, Double Blind, Parallel Group Trial in Moderate to Severe Plaque Psoriasis to Assess Safety and Efficacy After 16 Weeks of Treatment and After Inadequate Adalimumab Treatment Response (IMMvent)

Condition/Disease

plaque psoriasis
Test Drug

BI655066

Participate Sites
5Sites

Terminated5Sites

李婉若

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Dermatology

2016-01-01 - 2019-12-31

Phase IV

A Multi-Center, Open-Label, Single-Arm, Phase IV Study to Evaluate the Safety and Clinical Efficacy of Oral Administration with Nemonoxacin in Treating Elderly Patients with Community-Acquired Pneumonia

Condition/Disease

h Community-Acquired Pneumonia
Test Drug

Taigexyn

Participate Sites
9Sites

Terminated9Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

2016-04-01 - 2019-02-24

Phase II

A phase II study of autologous human dermal fibroblasts for the treatment of moderate to severe nasolabial fold wrinkles in adults

Condition/Disease

moderate to severe nasolabial fold wrinkles
Test Drug

無

Participate Sites
1Sites

Terminated1Sites

李婉若

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Dermatology

2018-01-01 - 2022-01-31

Phase I

A Phase I/II Study to Evaluate the Safety and Efficacy of Allogeneic Infusion of Adipose-Derived Stem Cells in Moderate to Severe Chronic Kidney Disease

Condition/Disease

Moderate to Severe Chronic Kidney Disease (stage 3B to 4)
Test Drug

ELIXCYTE

Participate Sites
3Sites

Recruiting3Sites

吳麥斯

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Nephrology

Search Result

List